Literature DB >> 10964986

ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers.

O Dolezal1, L A Pearce, L J Lawrence, A J McCoy, P J Hudson, A A Kortt.   

Abstract

Synthetic genes encoding single-chain variable fragments (scFvs) of NC10 anti-neuraminidase antibody were constructed by joining the V(L) and V(H) domains with linkers of fifteen, five, four, three, two, one and zero residues. These V(L)-V(H) constructs were expressed in Escherichia coli and the resulting proteins were characterized and compared with the previously characterized NC10 scFv proteins assembled in V(H)-V(L) orientation. Size-exclusion chromatography and electron microscope images of complexes formed between various NC10 scFvs and anti-idiotype Fab' were used to analyse the oligomeric status of these scFvs. The result showed that as the linker length between V(L) and V(H) was reduced, different patterns of oligomerization were observed compared with those with V(H)-V(L) isomers. As was the case for V(H)-V(L) orientation, the scFv-15 V(L)-V(H) protein existed mainly as a monomer whereas dimer (diabody) was a predominant conformation for the scFv-5, scFv-4 and scFv-3 V(L)-V(H) proteins. In contrast to the V(H)-V(L) isomer, direct ligation of V(L) to V(H) led to the formation of predominantly a tetramer (tetrabody) rather than to an expected trimer (triabody). Furthermore, the transition between dimers and higher order oligomers was not as distinct as for V(H)-V(L). Thus reducing the linker length in V(L)-V(H) from three to two residues did not precisely dictate a transition between dimers and tetramers. Instead, two-residue as well as one-residue linked scFvs formed a mixture of dimers, trimers and tetramers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964986     DOI: 10.1093/protein/13.8.565

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  27 in total

1.  Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors:  Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

2.  Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody.

Authors:  Ryutaro Asano; Keiko Ikoma; Yukiko Sone; Hiroko Kawaguchi; Shintaro Taki; Hiroki Hayashi; Takeshi Nakanishi; Mitsuo Umetsu; Yu Katayose; Michiaki Unno; Toshio Kudo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

Review 3.  Antibody vectors for imaging.

Authors:  Tove Olafsen; Anna M Wu
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

4.  Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.

Authors:  Ryutaro Asano; Keiko Ikoma; Ippei Shimomura; Shintaro Taki; Takeshi Nakanishi; Mitsuo Umetsu; Izumi Kumagai
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

5.  Creation and Evaluation of a Single-chain Antibody Tetramer that Targets Brain Endothelial Cells.

Authors:  Xiaobin Zhang; Xin Xiang Wang; Eric V Shusta
Journal:  AIChE J       Date:  2014-04-01       Impact factor: 3.993

6.  A fully human scFv phage display library for rapid antibody fragment reformatting.

Authors:  Keyu Li; Kirstin A Zettlitz; Julia Lipianskaya; Yu Zhou; James D Marks; Parag Mallick; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2015-05-19       Impact factor: 1.650

Review 7.  Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications.

Authors:  Eric C Peterson; W Brooks Gentry; S Michael Owens
Journal:  Adv Pharmacol       Date:  2014

8.  Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Authors:  Jeffrey V Leyton; Tove Olafsen; Mark A Sherman; Karl B Bauer; Patrick Aghajanian; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2008-10-28       Impact factor: 1.650

9.  ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

Authors:  Tove Olafsen; Shannon J Sirk; David J Betting; Vania E Kenanova; Karl B Bauer; Waldemar Ladno; Andrew A Raubitschek; John M Timmerman; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2010-01-06       Impact factor: 1.650

10.  On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.

Authors:  Ravikumar Rajamanonmani; Celine Nkenfou; Paula Clancy; Yin Hoe Yau; Susana Geifman Shochat; Soila Sukupolvi-Petty; Wouter Schul; Michael S Diamond; Subhash G Vasudevan; Julien Lescar
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.